My clinical service and academic interests focus on implementing new tests for in vitro diagnosis and to improve quality of testing by promoting excellence in automation, toxicology and point of care areas of laboratory.

Dr. Budelier the Medical Director of Clinical Chemistry and Toxicology at TriCore Reference Laboratories and Clinical Assistant Professor of Pathology at the University of New Mexico. Her research interests are broadly focused on developing clinically useful, mass spectrometry-based assays to improve diagnosis and treatment of human disease. Her expertise are in Toxicology/TDM, assay development and validation, and protein quantification.

Dustin R. Bunch, is an Asst. Director of Clinical Chemistry & Co-Director Laboratory Informatics at Nationwide Children's Hospital. His research focuses small molecule analysis by mass spectrometry in a clinical setting and clinical informatics.

I received my PhD from University of Florida in 2016, where I developed ion mobility-mass spectrometry (IM-MS) methods for steroids and vitamin D metabolites. I then worked as a post-doctoral research at Pacific Northwest National Laboratory, building Structures for Loss Ion Manipulations (SLIM) ion mobility instrumentation for application in metabolomics and proteomics. In 2018, I began my independent career as an Assistant Professor at Florida Institute of Technology. I have since moved to Clemson University in August 2022. Work in my research group focuses on ion mobility-mass spectrometry (IM-MS)-based methods and technology, including structurally selective reactions for improved characterization of steroids and other controlled substances.

Pankaj has expertise in cancer biology, quantitative proteomics-phosphoproteomics, protein biochemistry, and proteomics data analysis. He has published seminal scientific papers on the cytokine receptor biology and its role in leukemia. His sphere of experience and interest includes but not limited to cell cultures, mouse models, processing proteomics samples and operating nano-LC-MS/MS. He has in-depth knowledge and understanding of quantitative proteomics techniques, e.g. SILAC, TMT, iTRAQ and RABA and understanding of aberrant proteomics as well as phospho-signaling and global ubiquitin profiles of solid and liquid tumor models.

Oleg Karaduta holds faculty position at University of Arkansas for Medical Sciences. His research focuses on development of mass spectrometry-based proteomics tools for the analysis of protein-protein interaction networks and for metaproteomics.

I have obtained a degree as an Engineer in Chemistry focusing on analytical biochemistry, followed by a masters and PhD in Biochemistry (SS Cyril and Methodius University, N Macedonia) with a major focus on clinical proteomics and MALDI mass spectrometry. I have furthered my experience in a clinical laboratory (Clinic of Neurology), academia (The Biodesign Institute, ASU) and Industry (HealthTell Inc ). I am fascinated by mass spectrometry and the unambiguity it possess. I am currently a Senior Scientist at Cowper Sciences Inc, where I am focusing on exploring/applying novel methods and techniques in proteomics research, with potential for operation and commercialization.